FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103938232> ?p ?o ?g. }

• W2103938232 endingPage "3090" @default.
• W2103938232 startingPage "3083" @default.
• W2103938232 abstract "To retrospectively evaluate the pattern of recurrence and outcome of node-negative breast cancer (BC) according to major subtypes.In all, 1,951 patients with node-negative, early-stage BC randomly assigned in International Breast Cancer Study Group Trials VIII and IX with centrally reviewed pathology data were included. BC subtypes were defined as triple negative (TN; n = 310), human epidermal growth factor receptor 2 (HER2) positive (n = 369), and hormone receptor positive with high (luminal B-like [LB-like]; n = 763) or low (luminal A-like [LA-like]; n = 509) proliferative activity by Ki-67 labeling index. BC-free interval (BCFI) events were invasive BC recurrence in local, contralateral breast, nodal, bone, or visceral sites. Time to first site-specific recurrence was evaluated by using cumulative incidence and competing risks regression analysis.Median follow-up was 12.5 years. The 10-year BCFI was higher for patients with LA-like (86%) BC compared with LB-like (76%), HER2 (73%), and TN (71%; P < .001) BC. TN and HER2 cohorts had higher hazard of BCFI event in the first 4 years after diagnosis (pre-trastuzumab). LB-like cohorts had a continuously higher hazard of BCFI event over time compared with LA-like cohorts. Ten-year overall survival was higher for LA-like (89%) compared with LB-like (83%), HER2 (77%), and TN (75%; P < .001) BC. LB-like subtypes had higher rates of bone as first recurrence site than other subtypes (P = .005). Visceral recurrence as first site was lower for the LA-like subgroup, with similar incidence among the other subgroups when treated with chemotherapy (P = .003).BC subtypes have different distant recurrence patterns over time. Defining different patterns of BC recurrence can improve BC care through surveillance guidelines and can guide the design of clinical studies." @default.
• W2103938232 created "2016-06-24" @default.
• W2103938232 creator A5008032796 @default.
• W2103938232 creator A5024584289 @default.
• W2103938232 creator A5025554206 @default.
• W2103938232 creator A5036344172 @default.
• W2103938232 creator A5038599053 @default.
• W2103938232 creator A5040290360 @default.
• W2103938232 creator A5049115066 @default.
• W2103938232 creator A5064012830 @default.
• W2103938232 creator A5066013189 @default.
• W2103938232 creator A5073000306 @default.
• W2103938232 creator A5088697304 @default.
• W2103938232 date "2013-09-01" @default.
• W2103938232 modified "2023-10-17" @default.
• W2103938232 title "Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX" @default.
• W2103938232 cites W1497822707 @default.
• W2103938232 cites W1546709038 @default.
• W2103938232 cites W1773938361 @default.
• W2103938232 cites W1948838904 @default.
• W2103938232 cites W1961026612 @default.
• W2103938232 cites W1974026856 @default.
• W2103938232 cites W1992137963 @default.
• W2103938232 cites W1999463736 @default.
• W2103938232 cites W2038981426 @default.
• W2103938232 cites W2041282815 @default.
• W2103938232 cites W2042450298 @default.
• W2103938232 cites W2055918375 @default.
• W2103938232 cites W2070086300 @default.
• W2103938232 cites W2085261371 @default.
• W2103938232 cites W2097255042 @default.
• W2103938232 cites W2100849885 @default.
• W2103938232 cites W2105376289 @default.
• W2103938232 cites W2112894406 @default.
• W2103938232 cites W2116760308 @default.
• W2103938232 cites W2130252153 @default.
• W2103938232 cites W2131994307 @default.
• W2103938232 cites W2132893003 @default.
• W2103938232 cites W2137853125 @default.
• W2103938232 cites W2138929540 @default.
• W2103938232 cites W2143184226 @default.
• W2103938232 cites W2152190583 @default.
• W2103938232 cites W2152578842 @default.
• W2103938232 cites W2157840751 @default.
• W2103938232 cites W2162155075 @default.
• W2103938232 cites W2165168884 @default.
• W2103938232 cites W2166311434 @default.
• W2103938232 cites W2167105148 @default.
• W2103938232 cites W2171015116 @default.
• W2103938232 cites W2541820485 @default.
• W2103938232 cites W3128877721 @default.
• W2103938232 cites W4253111969 @default.
• W2103938232 doi "https://doi.org/10.1200/jco.2012.46.1574" @default.
• W2103938232 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3753700" @default.
• W2103938232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23897954" @default.
• W2103938232 hasPublicationYear "2013" @default.
• W2103938232 type Work @default.
• W2103938232 sameAs 2103938232 @default.
• W2103938232 citedByCount "258" @default.
• W2103938232 countsByYear W21039382322013 @default.
• W2103938232 countsByYear W21039382322014 @default.
• W2103938232 countsByYear W21039382322015 @default.
• W2103938232 countsByYear W21039382322016 @default.
• W2103938232 countsByYear W21039382322017 @default.
• W2103938232 countsByYear W21039382322018 @default.
• W2103938232 countsByYear W21039382322019 @default.
• W2103938232 countsByYear W21039382322020 @default.
• W2103938232 countsByYear W21039382322021 @default.
• W2103938232 countsByYear W21039382322022 @default.
• W2103938232 countsByYear W21039382322023 @default.
• W2103938232 crossrefType "journal-article" @default.
• W2103938232 hasAuthorship W2103938232A5008032796 @default.
• W2103938232 hasAuthorship W2103938232A5024584289 @default.
• W2103938232 hasAuthorship W2103938232A5025554206 @default.
• W2103938232 hasAuthorship W2103938232A5036344172 @default.
• W2103938232 hasAuthorship W2103938232A5038599053 @default.
• W2103938232 hasAuthorship W2103938232A5040290360 @default.
• W2103938232 hasAuthorship W2103938232A5049115066 @default.
• W2103938232 hasAuthorship W2103938232A5064012830 @default.
• W2103938232 hasAuthorship W2103938232A5066013189 @default.
• W2103938232 hasAuthorship W2103938232A5073000306 @default.
• W2103938232 hasAuthorship W2103938232A5088697304 @default.
• W2103938232 hasBestOaLocation W21039382322 @default.
• W2103938232 hasConcept C120665830 @default.
• W2103938232 hasConcept C121332964 @default.
• W2103938232 hasConcept C121608353 @default.
• W2103938232 hasConcept C126322002 @default.
• W2103938232 hasConcept C143998085 @default.
• W2103938232 hasConcept C207103383 @default.
• W2103938232 hasConcept C23589133 @default.
• W2103938232 hasConcept C2779786085 @default.
• W2103938232 hasConcept C2780849966 @default.
• W2103938232 hasConcept C44249647 @default.
• W2103938232 hasConcept C50382708 @default.
• W2103938232 hasConcept C530470458 @default.
• W2103938232 hasConcept C61511704 @default.
• W2103938232 hasConcept C71924100 @default.
• W2103938232 hasConcept C72563966 @default.

• next